<DOC>
	<DOCNO>NCT00171717</DOCNO>
	<brief_summary>The trial conduct patient receive liver transplant , prescribed tacrolimus prevent organ rejection develop diabetes 3 month post-transplantation onwards . The goal trial assess percentage patient diabetes resolve 6 month conversion tacrolimus cyclosporine micro-emulsion measure fasting blood glucose &lt; 1,26 g/l without need hypoglycemic treatment .</brief_summary>
	<brief_title>Conversion From Tacrolimus Cyclosporine Microemulsion Liver Transplant Patients With New Onset Diabetes After 3rd Month Post-transplant</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Patients receive first liver transplantation 18 70 year old Patients treat tacrolimus posttransplant least 3 month maximum 36 month Patients without know diabetes transplantation diabetes mellitus diagnose first time least 3 month posttransplantation Exclusion Criteria Retransplantation multiorgan transplantation , Diabetes transplantation , Type I diabetes mellitus . Other protocoldefined inclusion / exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Cyclosporine , liver transplantation , maintenance , diabetes</keyword>
</DOC>